Agentic AI for Structural Elucidation and Discovery of Drug Metabolites from Mass Spectrometry Data
The majority of chemical signals detected in public metabolomics repositories remain structurally undefined. Large language models (LLMs) are probabilistic systems whose capacity to generate outputs beyond their training data, which can cause hallucinations, makes them also potentially suited to hypothesize structures for molecules that have never been described. We aimed to build a system that could harness this LLM generative capacity combined with domain specific tools/framework to constrain hallucination and produce validated discoveries. We developed a GNPS2 agentic AI system that interprets LC-MS/MS data by integrating spectral alignment, molecular formula inference, rule-based structural enumeration, machine learning-based spectrum prediction, and translates natural language hypotheses from domain experts into dynamically generated analytical workflows. We demonstrate the annotation of unknown drug metabolites from public data guided by chemical hypotheses. The agent predicted, and we experimentally confirmed, a phosphorylated hydroxyzine, an acetaminophen-p-coumaric acid ester, and identified two new oxidative ibuprofen-carnitine conjugates from public repositories. These results demonstrate that LLM-driven agentic reasoning, when combined with domain expertise, can indeed generate experimentally testable structural hypotheses for previously uncharacterized metabolites leveraging pan repository data.